FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Eflornithine Hydrochloride (Vaniqa) Cream
Status: Currently in Shortage
»Date first posted: 04/18/2018
»Therapeutic Categories: Dermatology

Allergan (Revised 10/15/2018)

Company Contact Information:
800-678-1605

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
13.9% (NDC 0023-4857-45) Unavailable. Recovery expected January 2019 Shortage of active ingredient

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English